113 related articles for article (PubMed ID: 2305591)
1. Group I pepsinogen for early detection of gastric cancer recurrence after total gastrectomy.
Kodama M; Koyama K; Tsuburaya Y; Ishikawa K; Koyama H; Narisawa T; Uesaka Y
World J Surg; 1990; 14(1):94-9; discussion 99-100. PubMed ID: 2305591
[TBL] [Abstract][Full Text] [Related]
2. Urinary pepsinogen I as a tumor marker of stomach cancer after total gastrectomy.
Yamaguchi T; Takahashi T; Yokota T; Kitamura K; Noguchi A; Kamiguchi M; Doi M; Ahn T; Sawai K; Yamane T
Cancer; 1991 Aug; 68(4):906-9. PubMed ID: 1649690
[TBL] [Abstract][Full Text] [Related]
3. [Group I pepsinogen (PG I) in the serum and urine after total gastrectomy].
Kodama M; Takahashi T; Kida K; Yamaguchi T
Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):686-93. PubMed ID: 6493192
[TBL] [Abstract][Full Text] [Related]
4. Pepsinogen isozymes in Borrmann IV type gastric carcinoma.
Nakamura K; Sue H
Tohoku J Exp Med; 1985 Jan; 145(1):39-47. PubMed ID: 3885479
[TBL] [Abstract][Full Text] [Related]
5. [A clinical study of pepsinogen I and II producing gastric carcinomas].
Kodoi A; Haruma K; Yoshihara M; Shimamoto T; Watanabe C; Okamoto S; Kawaguchi H; Tari A; Sumii K; Kajiyama G
Nihon Shokakibyo Gakkai Zasshi; 1993 Dec; 90(12):2971-8. PubMed ID: 8283807
[TBL] [Abstract][Full Text] [Related]
6. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
8. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
[TBL] [Abstract][Full Text] [Related]
9. A rare case of recurrent alpha-fetoprotein-producing gastric cancer without re-elevation of serum AFP.
Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Shimizu N; Soda M
J Int Med Res; 2006; 34(1):109-14. PubMed ID: 16604831
[TBL] [Abstract][Full Text] [Related]
10. False-positive findings for tumor markers after curative gastrectomy for gastric cancer.
Ohtsuka T; Sato S; Kitajima Y; Tanaka M; Nakafusa Y; Miyazaki K
Dig Dis Sci; 2008 Jan; 53(1):73-9. PubMed ID: 17476595
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach.
Westerveld BD; Pals G; Défize J; Pronk J; Frants RR; Kreuning J; Eriksson AW; Meuwissen SG
Prog Clin Biol Res; 1985; 173():201-12. PubMed ID: 3885251
[TBL] [Abstract][Full Text] [Related]
12. Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always necessary.
Sugoor P; Shah S; Dusane R; Desouza A; Goel M; Shrikhande SV
Langenbecks Arch Surg; 2016 Aug; 401(5):687-97. PubMed ID: 27143021
[TBL] [Abstract][Full Text] [Related]
13. Recurrence following laparoscopy-assisted gastrectomy for gastric cancer: a multicenter retrospective analysis of 1,417 patients.
Song J; Lee HJ; Cho GS; Han SU; Kim MC; Ryu SW; Kim W; Song KY; Kim HH; Hyung WJ;
Ann Surg Oncol; 2010 Jul; 17(7):1777-86. PubMed ID: 20151217
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical study and cellular localization of human pepsinogens during ontogenesis and in gastric cancers.
Hirsch-Marie H; Loisillier F; Touboul JP; Burtin P
Lab Invest; 1976 Jun; 34(6):623-32. PubMed ID: 778486
[TBL] [Abstract][Full Text] [Related]
15. Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers.
Ohtsuka T; Nakafusa Y; Sato S; Kitajima Y; Tanaka M; Miyazaki K
Dig Dis Sci; 2008 Jun; 53(6):1537-43. PubMed ID: 17932750
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
17. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
Hengels KJ; Strohmeyer G
Z Gastroenterol; 1989 Aug; 27(8):406-11. PubMed ID: 2609705
[TBL] [Abstract][Full Text] [Related]
18. PG I and PG II show unique value in diagnosing postoperative biochemical recurrence in patients with gastric cancer after total gastrectomy.
Zhang J; Liu J; Dong L; Wang X; Mao X; Mao Y; Mao C
Discov Oncol; 2024 Jun; 15(1):231. PubMed ID: 38884851
[TBL] [Abstract][Full Text] [Related]
19. The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer.
Sawayama H; Iwatsuki M; Kuroda D; Toihata T; Uchihara T; Koga Y; Yagi T; Kiyozumi Y; Eto T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Baba H
Surg Today; 2018 Nov; 48(11):994-1003. PubMed ID: 29926189
[TBL] [Abstract][Full Text] [Related]
20. Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.
Konishi N; Matsumoto K; Hiasa Y; Kitahori Y; Hayashi I; Matsuda H
J Clin Pathol; 1995 Apr; 48(4):364-7. PubMed ID: 7615858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
